Construction of Fab expression plasmids

WD Wanwisa Dejnirattisai
DZ Daming Zhou
HG Helen M. Ginn
HD Helen M.E. Duyvesteyn
PS Piyada Supasa
JC James Brett Case
YZ Yuguang Zhao
TW Thomas S. Walter
AM Alexander J. Mentzer
CL Chang Liu
BW Beibei Wang
GP Guido C. Paesen
JS Jose Slon-Campos
CL César López-Camacho
NK Natasha M. Kafai
AB Adam L. Bailey
RC Rita E. Chen
BY Baoling Ying
CT Craig Thompson
JB Jai Bolton
AF Alex Fyfe
SG Sunetra Gupta
TT Tiong Kit Tan
JG Javier Gilbert-Jaramillo
WJ William James
MK Michael Knight
MC Miles W. Carroll
DS Donal Skelly
CD Christina Dold
YP Yanchun Peng
RL Robert Levin
TD Tao Dong
AP Andrew J. Pollard
JK Julian C. Knight
PK Paul Klenerman
NT Nigel Temperton
DH David R. Hall
MW Mark A. Williams
NP Neil G. Paterson
FB Felicity K.R. Bertram
CS C. Alistair Siebert
DC Daniel K. Clare
AH Andrew Howe
JR Julika Radecke
YS Yun Song
AT Alain R. Townsend
KH Kuan-Ying A. Huang
EF Elizabeth E. Fry
JM Juthathip Mongkolsapaya
MD Michael S. Diamond
request Request a Protocol
ask Ask a question
Favorite

Heavy chain expression plasmids of specific antibodies were used as templates to amplify the first fragment, heavy chain vector include the variable region and CH1 until Kabat amino acid number 233. The second fragment of thrombin cleavage site and twin-Strep-tag with overlapping ends to the first fragment were amplified. The two fragments were ligated by Gibson assembly to make the Fab heavy chain expression plasmid.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A